Literature DB >> 1928840

Application of engineered chimeric antibodies to the calibration of human antibody standards.

R G Hamilton1.   

Abstract

Immunoassay quantitation of human antibody depends on the availability of reference sera that have been characterized in terms of their antibody content. This report expands upon the concept of "cross-calibration", using reference (dose-response) curves that have been generated with heterologous antibody as a means of calibrating prospective human antibody standards. Engineered human-mouse chimeric antibody, with a single human isotype and specificity, is used to construct the heterologous dose-response curve from which test antibody response data are interpolated. Transfer experiments are used to define and correct for the percentage of the total chimeric antibody that is immunoreactive and bound to solid phase antigen. The chimeric antibody-based calibration procedure is illustrated using H. influenzae Type B as the model antigen and an engineered chimeric IgG1 antibody that has a known mass per volume content and specificity for the hapten, 4-hydroxy-3-nitro-phenylacetyl (NP).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928840

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  10 in total

1.  Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

Authors:  K R Lottenbach; C M Mink; S J Barenkamp; E L Anderson; S M Homan; D C Powers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.

Authors:  A Soininen; I Seppälä; T Wuorimaa; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

3.  Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to Toxoplasma gondii.

Authors:  J Hackett; J Hoff-Velk; A Golden; J Brashear; J Robinson; M Rapp; M Klass; D H Ostrow; W Mandecki
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  T Y Ling; T J Sims; H A Chen; C W Whitney; B J Moncla; L D Engel; R C Page
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

5.  Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide.

Authors:  M E Wilson; R G Hamilton
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.

Authors:  P K Holder; S E Maslanka; L B Pais; J Dykes; B D Plikaytis; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

7.  Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.

Authors:  Helen Joseph; Paul Balmer; Mike Bybel; Thomas Papa; Robert Ryall; Ray Borrow
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

8.  Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.

Authors:  T Barington; M Skettrup; L Juul; C Heilmann
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans.

Authors:  M E Wilson; R G Hamilton
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.

Authors:  Bailin Tu; Robert N Ziemann; Bryan C Tieman; David J Hawksworth; Joan Tyner; James Scheffel; Mary S Pinkus; Susan E Brophy; Jeffrey M Werneke; Robin Gutierrez; Michael White
Journal:  Clin Vaccine Immunol       Date:  2010-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.